FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

414289007: Formoterol (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2005. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2531468013 Formoterol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2534998012 Formoterol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2537703011 Eformoterol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2531468013 Formoterol (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2531468013 Formoterol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2534998012 Formoterol en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2534998012 Formoterol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2537703011 Eformoterol en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2537703011 Eformoterol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
58001000195111 formoterolo it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
73161000195116 Formoterol de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
813241000172110 formotérol fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
813241000172110 formotérol fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
58001000195111 formoterolo it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
73161000195116 Formoterol de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Formoterol Is a Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Formoterol Is a Respiratory sympathomimetic agent false Inferred relationship Existential restriction modifier (core metadata concept)
Formoterol Has disposition Beta adrenergic receptor agonist (disposition) false Inferred relationship Existential restriction modifier (core metadata concept)
Formoterol Has disposition Beta-2 adrenergic receptor agonist true Inferred relationship Existential restriction modifier (core metadata concept)
Formoterol Is a Ethanolamine and/or ethanolamine derivative true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Formoterol fumarate (substance) Is a False Formoterol Inferred relationship Existential restriction modifier (core metadata concept)
Product containing budesonide and formoterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 2
Budesonide 80mcg/formoterol 4.5mcg dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Formoterol Inferred relationship Existential restriction modifier (core metadata concept)
Budesonide 160mcg/formoterol 4.5mcg dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Formoterol Inferred relationship Existential restriction modifier (core metadata concept)
Budesonide 320mcg/formoterol 9mcg dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Formoterol Inferred relationship Existential restriction modifier (core metadata concept)
Product containing formoterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 1
Budesonide+eformoterol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Formoterol Inferred relationship Existential restriction modifier (core metadata concept)
Budesonide+eformoterol fumarate 200/6mcg bth-act dry pdr inh (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Formoterol Inferred relationship Existential restriction modifier (core metadata concept)
Budesonide+eformoterol fumarate 100/6mcg bth-act dry pdr inh (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Formoterol Inferred relationship Existential restriction modifier (core metadata concept)
Budesonide+eformoterol fumarate dihydrate 400micrograms/12micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Formoterol Inferred relationship Existential restriction modifier (core metadata concept)
Formoterol 20micrograms inhalation solution 2mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Formoterol Inferred relationship Existential restriction modifier (core metadata concept)
Product containing formoterol and mometasone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing formoterol and glycopyrronium bromide The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Formoterol Inferred relationship Existential restriction modifier (core metadata concept)
Product containing formoterol and glycopyrronium bromide in respiratory dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Formoterol Inferred relationship Existential restriction modifier (core metadata concept)
Formoterol fumarate (substance) Is modification of (attribute) True Formoterol Inferred relationship Existential restriction modifier (core metadata concept)
Formoterol-containing product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing budesonide and formoterol in pulmonary dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 2
Budesonide and formoterol only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 2
Formoterol only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 1
Formoterol and mometasone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 2
Formoterol only product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 1
Budesonide and formoterol only product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has basis of strength substance (attribute) False Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has precise active ingredient False Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely budesonide 80 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has precise active ingredient False Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely budesonide 80 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Has basis of strength substance (attribute) False Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing aclidinium and formoterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only aclidinium and formoterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 1
Aclidinium- and formoterol-containing product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 1
Aclidinium and formoterol only product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 1
Formoterol and tiotropium only product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 2
Formoterol and tiotropium only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 2
Formoterol- and tiotropium-containing product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing formoterol and tiotropium (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing ciclesonide and formoterol and tiotropium (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 2
Ciclesonide- and formoterol- and tiotropium-containing product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing only ciclesonide and formoterol and tiotropium in pulmonary dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 2
Ciclesonide and formoterol and tiotropium only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 2
Fluticasone and formoterol only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 2
Fluticasone- and formoterol-containing product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing fluticasone and formoterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 2
Fluticasone and formoterol only product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Formoterol Inferred relationship Existential restriction modifier (core metadata concept) 2

This concept is not in any reference sets

Back to Start